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Abstract: The aim of this work was to determine the effect of a fructose rich diet (FRD) consumed by
the pregnant mother on the endocrine-metabolic and in vivo and in vitro adipose tissue (AT) functions
of the male offspring in adulthood. At 60 days of age, rats born to FRD-fed mothers (F) showed
impaired glucose tolerance after glucose overload and high circulating levels of leptin (LEP). Despite
the diminished mass of retroperitoneal AT, this tissue was characterized by enhanced LEP gene
expression, and hypertrophic adipocytes secreting in vitro larger amounts of LEP. Analyses of stromal
vascular fraction composition by flow cytometry revealed a reduced number of adipocyte precursor
cells. Additionally, 60 day-old control (C) and F male rats were subjected to control diet (CC and
FC animals) or FRD (CF and FF rats) for three weeks. FF animals were heavier and consumed
more calories. Their metabolic-endocrine parameters were aggravated; they developed severe
hyperglycemia, hypertriglyceridemia, hyperleptinemia and augmented AT mass with hypertrophic
adipocytes. Our study highlights that manipulation of maternal diet induced an offspring phenotype
mainly imprinted with a severely unhealthy adipogenic process with undesirable endocrine-metabolic
consequences, putting them at high risk for developing a diabetic state.
Keywords: metabolic programming; adipocyte precursor cells; dysfunctional adipose tissue; altered
glucose tolerance; insulin resistance; pre-diabetes; metabolic syndrome
1. Introduction
Metabolic Syndrome (MS), obesity and type 2 diabetes have drastically increased to epidemic
levels worldwide in the last few decades. The World Health Organization has defined obesity as an
increment in adipose tissue (AT) mass which may or may not be detrimental to health [1]. These
illnesses have been attributed mainly to changes in lifestyle, including dietary habits. Fructose rich diet
(FRD) consumption has been shown to be associated with insulin resistance [2], hyperadiposity,
hypertriglyceridemia, hyperleptinemia [3], hyperglycemia, hyperinsulinemia, impaired glucose
tolerance [4] and hepatic steatosis [5], in both animal models and humans.
Diseases in adulthood may originate during an individual’s development, due to changes in the
environment in which the individual is subjected to [6]. Factors that may alter the environment can
include maternal nutrition, either during gestation and lactation [7,8]. Several studies highlighted the
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undesirable consequences of maternal unbalanced diet intake during gestation and/or lactation for the
offspring’s health in adult life [9,10]. Different works have focused on the effects of feeding mothers
a FRD during gestation and lactation, showing that their offspring displayed an increased risk of
developing obesity in adult life [11,12]. We previously reported deleterious metabolic-endocrine
function of pups born to FRD-fed lactating mothers [13]. These pups developed changes in
the hypothalamic circuitry controlling appetite, impaired peripheral insulin sensitivity, and both
hyperleptinemia and visceral adipocyte hypertrophy [13].
Carbohydrates are major metabolites involved in fetal growth and metabolism, and it is accepted
that fructose is present in fetal circulation [14]. The intake of refined sugar, particularly high-fructose
corn syrup, has increased in the United States from a yearly estimate of 8.1 kg/individual at the
beginning of the 19th century up to 65 kg/person in 2010 [15]. However, limited data exist on the
consequences of FRD intake through the mother for the offspring’s metabolic programming [16,17].
Indeed, most of the international literature showed studies wherein experimental designs were devoted
to mothers consuming FRD throughout gestation and lactation or only while lactating [11,18–20].
It was reported recently that adult male offspring born to FRD-fed dams throughout gestation
developed insulin resistance, dyslipidemia, a distorted pattern of peripheral adipokines and enhanced
oxidative stress [21]. Interestingly, later in life, the offspring normalized leptinemia, but became
hypoadiponectinemic [22]. Conversely, a recent study showed that FRD intake by gestating mothers
resulted in pronounced maternal dysfunctions but no major undesirable metabolic effects on offspring,
even after following their progress up to 6 months of age [23].
The current study was designed to test whether or not the feeding of mothers with a FRD
throughout gestation modifies endocrine-metabolic biomarkers and in vivo and in vitro AT functions
in adult male progeny. Moreover, we aimed to determine in utero fructose exposure impact on adult
rats challenged or not with a FRD during adult lifetime.
2. Materials and Methods
2.1. Animals and Experimental Designs
Sprague-Dawley (S-D) rats were kept in controlled conditions of temperature (21 ˘ 2 ˝C) and
lights (on between 07:00 a.m. and 7:00 p.m. with free access to standard commercial rat chow
(Ganave Lab., Argentina) and tap water. Virgin females (3 per cage) were mated with a male in
plastic cages until positive detection of sperm in their vaginal smears (daily examined at 08:00 a.m.).
Sperm positive dams were then individually housed and provided with standard chow ad libitum and
allocated into two groups: (a) drinking tap water only (control mothers, CM; n = 19); and (b) drinking
a FRD (fructose 10% w/v in tap water, fructose mothers, FM; n = 20) throughout pregnancy [24]. Fresh
fructose solution was provided every 2 days. Body weight (BW), food and fluid intakes were recorded
daily during pregnancy. Immediately after delivery, and as previously validated by our laboratory [13],
litter-size was adjusted to eight pups per dam (average male pups per litter ranged between 60% and
65%, approximately). Lactating mothers were provided with standard chow and water ad libitum.
Weaned (21 days old) male pups (born to CM and FM, assigned as C and F rats, respectively) were
individually housed and fed standard purina chow diet and tap water ad libitum until experimentation.
These groups of male rats (C and F) were made by including one male rat from each litter (see Figure 1).
Rats were euthanized following protocols in the National Institute of Health Guidelines for care and
use of experimental animals. All experiments also received approval from our Institutional Committee
on Animal Experimentation.
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Figure 1. Experimental design. Sper positi f t ad libitum were allocated
in two groups: drinking water (control mothers, CM, n = 19) and drinking FRD (fructose mothers,
FM, n = 20). This diet was maintained until delivery. During lactation, both mothers groups were
fed standard chow ad libitum and drink tap water. The weaning day, male pups born to CM and FM,
assigned as C and F rats, respectively, were fed standard purina chow diet and tap water ad libitum.
At 60 days of age, 6 C and 7 F males were killed for basal determinations and AT studies. Others 6 C
and 7 F rats were subjected to an i.v. GTT at 60 day-old. The remaining 16 C rats were divided in two
sub-groups; 10 animals receive water (CC) and 6 receive FRD (CF). The remaining 12 F animals, they
also were subdivided into two sub-groups; 6 animals receive water (FC) and 6 receive FRD (FF) from
day 60 until 81 days of age. Groups were made by including one male rat from each litter, so as not to
include pups from the same litter in the same experiment.
2.1.1. Sixty-Day-Old Rats
Six C and seven F rats were killed (08:00–09:00 a.m.) by decapitation in non-fasting conditions
and trunk blood was collected into plastic tubes containing EDTA (10% w/v, in normal saline
solution). Plasma samples were then stored frozen (´20 ˝C) until determination of several metabolites.
Immediately after euthanization, retroperitoneal adipose tissue (RPAT) pads were dissected and
weighed. RPAT was used for histological, gene expression, stromal vascul r fraction (SVF) cell
composition and adipocyte functiona studies (see b low). Additionally, six C and seven F rats were
subjected to intravenous glucose to erance test (i.v. GTT (Figure 1).
2.1.2. Eighty-One Day-Old Rats
Sixteen C and 12 F 60-day-old male rats were allocated to four sub-groups according to the
drinking solution provided, either tap water only CC (n = 10) and FC (n = 6) groups; or FRD CF
(n = 6) and FF (n = 6) groups (Figure 1). All groups were fed standard purina chow ad libitum and
treatments lasted for three weeks. Rat BW and food and fluid intakes were recorded daily. Rats were
killed by decapitation (08:00 a.m.) in non-fasting conditions. Trunk blood was collected and plasma
samples kept frozen (´20 ˝C) until measurement of different metabolites. Additionally, RPAT pads
were dissected, weighed, and used for histological studies.
2.2. RPAT Adipocyte Isolation and Incubation
Isolated adipocytes from RPAT pads were obtained as previously described [25]. Cells were
diluted to a density of approximately 200,000 cells per 900 µL of DMEM-1% BSA medium and
distributed into 5 mL plastic tubes. Substances t sted (diluted in 100 µL) wer either medium alone
(basal) or contained insulin (INS) (final concentrations: 0.1, 1 or 10 nM; Novo Nordisk Pharma AG,
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Switzerland) [26]. Adipocytes were then incubated for 45 min at 37 ˝C in a 95% air-5% CO2 atmosphere.
At the end of incubation, media were carefully aspirated and kept frozen (´20 ˝C) until measurement
of LEP concentrations as described below.
2.3. RPAT Pad Histology
For histological studies, freshly dissected RPAT pads were fixed in 4% paraformaldehyde, then
washed with tap water, immersed in a series of graded ethanol (70%, 96% and 100%), and clarified in
xylene before being embedded in paraffin [13]. Four-micrometer sections were taken from different
levels of the blocks and stained with hematoxylin-eosin. Quantitative morphometric analysis was
performed using a RGB CCD Sony camera together with Image Pro-Plus 4.0 software (magnification,
ˆ400). For each tissue sample, seven sections and three levels were selected (n = 4 animals per group).
Systematic random sampling was used to select 15 fields for each section, and 2500 cells per group
were examined. Adipocyte diameter was measured [24] and cell volume was later calculated (4/3pir3).
2.4. RNA Isolation and Real-Time Quantitative PCR
Total RNA was isolated from RPAT pads by the single-step acid guanidinium isothiocyanate-
phenol-chloroform extraction method (TRIzol; Invitrogen, LifeTech.). One µg of total RNA was
reverse-transcribed using random primers (0.2 µg/µL) and RevertAid Reverse Transcriptase (200 U/µL
Thermo Scientific). Primers applied were β-actin (ACTB; sense, 51-GGTCCACACCCGCCACCAG-31
and anti-sense, 51-GGGCCTCGTCGCCCACGTA-31; 200 bp; Gene Code: NM_031144.3), ADIPOQ
(sense, 51-AATCCTGCCCAGTCATGAAG-31 and anti-sense, 51-TCTCCAGGAGTGCCATCTCT-31;
159 bp; Gene Code: NM_144744.3) and LEP (sense, 51-GAGACCTCCTCCATCTGCTG-31 and anti-sense,
51-CTCAGCATTCAGGGCTAAGG-31; 192 bp; Gene Code: NM_013076.3). One microliter of the RT
mix was amplified with Hot FIREPol EvaGreen qPCR Mix Plus (Solis BioDyne) containing 0.5 µM of
each specific primer and using the Light Cycler Detection System (MJMini Opticon, Bio-Rad). PCR
efficiency was near 1. Threshold cycles (Ct) were measured in separate tubes by duplicate. Identity
and purity of the amplified product were checked by electrophoresis on agarose mini-gels, and the
melting curve was analyzed at the end of amplification. Relative changes in the expression levels of
one specific gene were calculated by ∆Ct analysis [13].
2.5. SVF Cell Composition Analysis by Flow Cytometry (FACS)
SVF cells from RPAT pads of C and F animals were isolated and at least 2 ˆ 105 cells (in 100 µL
PBS/0.5% BSA) incubated with fluorescent antibodies or respective isotype controls for 1 h at 4 ˝C. After
washing steps, flow cytometry was analyzed using a FACS Calibur flow cytometer (Becton Dickinson
Biosciences). A combination of surface cell markers were used to identify adipocyte precursor cells
(APCs) as: CD34+/CD45´/CD31´ [27]. Conjugated monoclonal antibodies used were: anti-rat
CD34:PE (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), anti-rat CD45:FITC (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA) and anti-rat CD31:FITC (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA). Samples were analyzed using CellQuest Pro (Becton-Dickinson, San Jose, CA,
USA) and FlowJo softwares (TreeStar, San Carlo, CA, USA) [27].
2.6. Intravenous Glucose Tolerance Test (i.v. GTT)
This test has been widely validated in our laboratory [13]. Briefly, 60 day-old C and F rats
(n = 6 C and n = 7 F rats) were subjected to an i.v. GTT. Rats were implanted (under light ketamine
anesthesia) with an i.v. cannula (in the right jugular vein 48 h before experimentation) kept patent by
administering heparin (10 U/mL in sterile saline solution: 100 µL). On the morning of the experimental
day (08:00–09:00 a.m.) a small volume of blood was taken in non-fasting condition before (time 0)
and 5, 15, 30, 60, and 90 min after i.v. glucose (GLU) (2 g/kg BW; dissolved in sterile saline solution)
administration [28]; the blood withdrawn was immediately replaced by a similar volume of sterile
artificial plasma. Plasma samples were kept frozen (´20 ˝C) until determination of GLU and INS
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concentrations. The area under the curve (AUC) was calculated with GraphPad Prism software using
basal (time 0) plasma GLU and INS as baseline.
2.7. Peripheral Metabolite Measurements
Circulating levels of GLU, triglycerides (TG) and total cholesterol (TC) were measured by
commercial kits (Wiener Lab., Rosario, Argentina). Plasma and medium LEP concentrations [25]
and circulating levels of INS [26] and corticosterone (CORT) [29] were determined by specific
radioimmunoassays (RIAs) previously validated. LEP (standard curve 0.05–25 ng/mL) coefficients
of variation (CV) intra- and inter-assay were 4%–7% and 9%–11%, respectively. INS (standard curve
0.08–10 ng/mL) CV intra- and inter-assay were 3%–7% and 8%–11%, respectively. CORT (standard
curve 0.05–50 µg/dL) CV intra- and inter-assay were 4%–6% and 8%–10%, respectively. Plasma
levels of adiponectin (ADIPOQ) were measured by commercial ELISA kit following manufacturer’s
instructions (Linco Research, Cat. #EZRADP-62 K, standard curve: 3–100 ng/mL CV intra- and
inter-assay were 0.43%–1.96% and 4.3%–8.44%, respectively).
2.8. Statistical Analysis
Results (expressed as means ˘ SEM) were analyzed by Student t-test when appropriate. One way
ANOVA followed by post hoc comparisons of mean values with the Newman Keuls test, was used
to compare different groups. ANOVA with repeated measures was used for analyses of i.v. GTT
values. Two-way ANOVA followed by Tukey’s multiple comparison test was used for analyses of the
effect of INS on LEP release by adipocytes; and for analyses of male caloric intake from weaning until
60 day-old. The non-parametric Mann-Whitney test was employed to analyze data on tissue mRNA
expression [13]. All data was analyzed using the software GraphPad Prism 6.0 on Windows (GraphPad
Software Inc., San Diego, CA, USA). P values lower than 0.05 were considered statistically significant.
3. Results
3.1. Pregnant Rats’ Body Weight and Food-Provided Energy Intake
The individual BW of pregnant rats were similar in both groups at the beginning (CM: 249.37
˘ 9.83 g, and FM: 244.28 ˘ 6.16 g; n = 19 CM and n = 20 FM) and at the end (CM: 366.86 ˘ 19.04 g,
and FM: 366.87 ˘ 10.11 g; n = 19 CM and n = 20 FM) of the gestational period. The 21-day average of
individual daily energy intake through diet was significantly higher in FM than in CM (84.71 ˘ 3.41 vs.
68.17 ˘ 5.07 kCal/day/100 g BW, respectively; p < 0.05, n = 19 CM and n = 20 FM).
3.2. Body Weight and Caloric Intake in Adult Male Offspring Born to CM and FM
The first male offspring born to CM and FM mothers (n = 12 and n = 14 rats in group C and F,
respectively) displayed similar BW between birth and 60 days of age (Figure 2A). No group-difference
was observed in 48 h-caloric intake corrected per 100g of BW (Figure 2B). Nevertheless, when a
two-way ANOVA analyses was performed, we observed that caloric intake is both influenced by time
and FRD intake during gestation was (p < 0.05). Even the interaction between these two factors was
statistically different (p < 0.05).
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Figure 2. Body weight and caloric intake. (A) Body weight and (B) mean 48 h cumulative caloric
intak corrected by 100 g of BW, betw en weaning and 60 ays of ge, in C and F rats. Values ar
means ˘ SEM (n = 12 and n = 14 rats in group C and F, respectively). FRD du ing gestation, ti , and
the interaction between them are considere significantly different between C and F rats, b sed on
two-way ANOVA.
3.3. Peripheral Levels of Several Metabolites and i.v. GTT in Adult Male Offspring
In non-fasting conditions, adult (60 day-old; n = 6 C rats and n = 7 F rats per group) F rats
displayed significantly (p < 0.05) higher circulating levels of LEP and lower levels of TG (Table 1).
Circulating concentrations of GLU, TC, CORT, INS and ADIPOQ remained the same (Table 1).
Table 1. Metabolic markers in 60 day-old rats.
C F
GLU (mmol/L) 6.58 ˘ 0.18 6.08 ˘ 0.24
TG (mmol/L) 1.44 ˘ 0.14 1.12 ˘ 0.06 *
TC (mmol/L) 1.56 ˘ 0.07 1.88 ˘ 0.13
CORT (nmol/L) 4.67 ˘ 1.08 3.43 ˘ 1.02
INS (nmol/L) 0.31 ˘ 0 02 0.26 ˘ 0.05
LEP (ng/mL) 2.41 ˘ 0.35 4.10 ˘ 0.31 *
ADIPOQ (µg/mL) 5.87 ˘ 0.72 5.60 ˘ 0.44
Circulating levels (in non-fasting conditions) of several metabolic markers in 60 day-old male rats born to either
normal diet (C)- or FRD (F)-fed mothers throughout pregnancy. Values are means ˘ SEM. n = 6 C rats and n = 7
F rats. * p < 0.05 vs. C values, based on Student’s t-test.
irculating GLU levels (Figure 3A) a d the AUC of these peripheral GLU levels (Figure 3B)
throughout the i.v. GTT were significantly (p < 0.05) igher in F than in C rats (n = 6 C and n = 7 F rats
per group). Moreover, while C rats did recover initial pl ma GLU values 60 min after GLU load, F
rats failed to do so (Figure 3A). The altered tolerance to GLU overload observed in F rats was related
to changes in INS secretion in plasma throughout the test. The profile of circulating levels of INS and
the AUC of INS values in both groups are depicted in Figure 3 (C and D, respectively). As shown,
plasma INS peak values (time 15 min) were significantly (p < 0.05) higher in F than in C rats (Figure 3C).
Moreover, we found a significantly (p < 0.05) higher AUC for INS values in F than in C rats (Figure 3D).
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Figure 3. Glucose Tolerance Test. Circulating levels of GLU (A), INS (C) and the area under the
curve (AUC) of GLU (B) and INS (D) during an i.v. GTT in C and F rats. Values are means ˘ SEM
(n = 6 C rats, and n = 7 F rats; # p < 0.05 vs. time-zero values in the same group, * p < 0.05 vs. C values in
similar conditions). One way ANOVA with repeated measures was used to compare different groups.
Student’s t-test was used for AUC differences.
3.4. Retroperitoneal Adipose Tissue Characteristics and Functionality in Adult Male Offspring
Whereas no difference was found in RPAT mass in 30 day-old C and F rats (data not shown),
RPAT fat mass was significantly (p < 0.05 vs. C) lower in F rats at 60 days of age (Table 2). However,
RPAT adipocyte diameter, area and volume were significantly (p < 0.05 vs. C) higher in F pads (Table 2
and Figure 4A,B, respectively).
Table 2. RPAT pad characteristics in 60 day-old rats.
C F
Pad mass (g per 100g BW) 0.71 ˘ 0.07 0.54 ˘ 0.03 *
Adipocyt diameter (µm) 37.21 ˘ 0.09 48.45 ˘ 0.28 *
Adipocyte area (µm2) 1182.34 ˘ 10.64 2057.79 ˘ 23.57 *
Adipocyte volume (µm3 ˆ 103) 26.97 ˘ 1.84 59.97 ˘ 3.47 *
LEP mRNA (AU) 1.09 ˘ 0.19 2.99 ˘ 0.18 *
ADIPOQ mRNA (AU) 1.28 ˘ 0.40 1.94 ˘ 0.41
RPAT pad characteristics in 60 day-old male rats born to either control diet- (C) or FRD-fed (F) mothers
throughout pregnancy. Values are means ˘ SEM. n = 6 C rats and n = 7 F rats. * p < 0.05 vs. C values; based on
Student’s t-test. mRNA expression levels were analyze by the non-parametric Mann-Whitney test.
Figure 4C shows the results of in vitro LEP release by isolated RPAT adipocytes incubated in
the a sence or presence of graded concentrations of INS. Spontaneous (INS 0 nM) LEP output was
significantly (p < 0.05) higher in the F than in the C cell-grou . While INS 0.1 nM failed to enhance
LEP secretion over the baseline in both groups of cells, INS 1 and 10 nM were able to significantly
(p < 0.05) increase LEP release over the baseline, regardless of the group examined. Interestingly, the
amount of LEP released into the medium was significantly (p < 0.05) higher in F than in C cell-media,
regardless of the condition examined (Figure 4C). These results tally with both circulating levels of LEP
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(Table 1) and the RPAT LEP mRNA expression levels in these rats (Table 2), although no significant
group-difference was noticed in the RPAT mRNA levels of ADIPOQ (Table 2). The adipogenic cell
population (CD34+/CD31´/CD45´ cells) in the RPAT SVF from both groups was evaluated in order
to assess a possible effect of maternal FRD intake on their APC number (Figure 4D,E). Interestingly,
maternal high fructose exposure significantly (p < 0.05 vs. C) decreased APC number (Figure 4F).
This result strongly suggests that the low APC number could be related to the finding of both RPAT
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Figure 4. RPAT Characteristics. (A and B) Histological characteristics, representative fields, in C (A)
and F (B) RPAT pads stained with hematoxylin eosin (scale bar: 50 µm; magnification: ˆ400); (C) Effects
of INS on LEP release by adipocytes. Values are means ˘ SEM (n = 4–5 different experiments; * p < 0.05
vs. C values in similar conditions, + p < 0.05 vs. 0 nM INS values in the same group, based on two way
ANOVA); (D and E) Representative dot plots showing the staining profile of RPAT SVF cells isolated
from C (D) and F (E) male adult rats; (F) Percentage of CD34+/CD45´/CD31´ cells, determined by
flow citometry. * p < 0.05 vs. C values, based on Student’s t-test.
3.5. Challenging Adult Male Offspring with a FRD
In these experiments, four groups of rats (CC, CF, FC and FF) were studied. The growth curves
of rats (studied over a 21 day-period: between 60 and 81 days of age) are shown in Figure 5A. Rat
BWs were similar in all groups on the initial day of diet administration. Throughout the indicated
period, energy intake (expressed as a 21 day-average) was similar in CC and CF rats. Conversely, this
parameter was significantly (p < 0.05) higher in FC than in CC rats. Notably, FF rats incorporated the
highest (p < 0.05 vs. remaining group-values) amount of energy (Figure 5B) and, as a result, FF rats
were heavier (p < 0.05 vs. CC rats) from day 68 until 81 days of age, although their final BWs were
similar to those from CF and FC rats (Figure 5A). Furthermore, no significant differences were found
in final BW values among CC, CF and FC rats (Figure 5A).
















basal  plasma  adiponectinemia,  and  FF  rats  were  unable  (as  CF  rats  did)  to  mount  their 
adiponectinemia  for protection against  the FRD  challenge applied; moreover,  they displayed  the 
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TC (mmol/L)  0.26 ± 0.03  0.23 ± 0.01  0.23 ± 0.001  0.21 ± 0.02 
CORT (nmol/L)  140.81 ± 37.41 87.45 ± 24.15  84.52 ± 12.99 190.98 ± 58.14 
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Figure 5. Body weight and mean caloric intake. (A) Body weight of male rats, born to CM or FM, fed
with either control diet (CC and FC groups) or FRD (CF and FF groups), since postnatal day 60 until
day 81; (B) Mean caloric intake of animals from four different groups. Values are means ˘ SEM. n = 10
CC rats, n = 6 CF rats, n = 6 FC rats and n = 6 FF rats. * p < 0.05 vs. CC values, + p < 0.05 vs. CF values, #
p < 0.05 vs. FC values, based on one way ANOVA.
When evaluated in basal conditions, CF animals displayed (Table 3) significantly (p < 0.05 vs.
CC values) higher circulating levels of TG, LEP and ADIPOQ; conversely, no difference in plasma
GLU and INS levels were noticed. FC rats displayed a severely distorted peripheral profile in several
endocrine-metabolic parameters: hyperglycemia, hypertriglyceridemia and hyperleptinemia (p < 0.05
vs. CC values) although unchanged plasma for INS, TC and CORT (Table 3 data indicating a highly
compromised basal metabolic state. Notably, both FC and FF rats showed similar (even vs. CC values)
basal plasma adiponectinemia, and FF rats were unable (as CF rats did) to mount their adiponectinemia
for protection against the FRD challenge applied; moreover, they displayed the highest peripheral
levels of GLU, TG and LEP, although with normoinsulinemia (Table 3).
Table 3. Metabolic markers in 81 day-old rats.
C CF FC FF
GLU (mmol/L) 4.96 ˘ 0.27 5.1 ˘ 0.33 5.88 ˘ 0.28 * 7.91˘ 0.56 *,+,#
TG (mmol/L) 1.19 ˘ 0.16 1.89 ˘ 0.17 * 1.7 ˘ 0.12 * 2.62 ˘ 0.11 *,+,#
C ( ol/L) 0.26 ˘ 0. 3 0.23 ˘ 0. 1 0.23 ˘ 0.00 0.21 ˘ 0.02
CORT (nmol/L) 140.81 ˘ 37.41 87.45 ˘ 24.15 84.52 ˘ 12.99 190.98 ˘ 58.14
INS (n ol/L) 0.28 ˘ 0.04 0.31 ˘ 0.04 0.37 ˘ 0.06 0.34 ˘ 0.05
LEP (ng/mL) 2.87 ˘ 0.14 3.89 ˘ 0.38 * 3.89 ˘ 0.43 * 5.57 ˘ 1.4 *
ADIPOQ (µg/mL) 14.82 ˘ 0.94 20.08 ˘ 2.77 * 13.61 ˘ 1.95 14.89 ˘ 2.72
Circulating levels (in non-fasting conditions) of plasma metabolites in 81 day-old male rats from different
groups. Values are means ˘ SEM. n = 10 CC rats, n = 6 CF rats, n = 6 FC rats and n = 6 FF rats.* p < 0.05 vs.
CC values, + p < 0.05 vs. CF values, # p < 0.05 vs. FC values, based on one-way ANOVA.
Regarding RPAT characteristics, we found that at 81 days-old, pad mass (in g per 100 g BW) was
significantly (p < 0.05 vs. CC values) increased in CF rats and that, although no pad mass difference was
observed in FC rats, FF rats also displayed an increased RPAT mass (p < 0.05 vs. CC values) (Figure 6E).
Figure 6A–D displays the morphological characteristics of adipocytes isolated from RPAT pads of
different groups. s expected [30], three-week-FRD administration to normal animals (CF group)
resulted in enlarged (p < 0.05 vs. CC) RPAT adipocytes (Figure 6F). Moreover, RPAT pads from rats
either challenged (FF) or not (FC) with a FRD at adult age displayed hypertrophic adipocytes (p < 0.05
vs. CC values), the first being the largest (Figure 6F).
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Figure 6. RPAT characteristics. Representative fields of RPAT pads from CC (A), CF (B), FC (C) and FF
(D) rats stained with hematoxylin eosin (scale bar: 50 µm; magnification: ˆ400); Additionally, RPAT
mass (E) and, adipocyte diameter (F) from different groups is displayed. Values are means ˘ SEM.
n = 10 CC rats, n = 6 CF rats, n = 6 FC rats and n = 6 FF rats. * p < 0.05 vs. CC values, + p < 0.05 vs.
CF values; # p < 0.05 vs. FF values, based on one-way ANOVA.
4. Discussion
Our results clearly demonstrate a deleterious effect on male offspring’s endocrine-metabolic
and adiposity functions induced by feeding pregnant rats a FRD. The consequences of this diet
intake by the pregnant mother were evident when pups reached 60 days of age. At that time,
male offspring showed dyslipidemia, hyperleptinemia, impaired glucose tolerance and adipocyte
hypertrophy; several dysfunctions were further aggravated after offspring were re-challenged with
FRD for three weeks.
Epidemiological and experimental studies demonstrated a relationship between maternal
nutrition and long-term metabolic consequences in the offspring. Under-/malnourishment [31–33] or
over-nourishment [34,35] in pregnant mothers induces in their offspring severe endocrine, metabolic
and adiposity dysfunctions. In effect, FRD intake during both pre- and early post-natal periods impairs
INS and LEP cell signaling, thereby modifying carbohydrate metabolism in the progeny [11,16,19].
Previous studies have shown that mothers consuming a FRD during both gestation and lactation
resulted in offspring characterized by dyslipidemia [36] and insulin resistance [37]. Other studies
showed that offspring consumption of a rich carbohydrate-milk during lactation increased plasma
levels of INS and LEP, and also BW, resulting in pancreatic disorders [12,32,33]. Moreover, FRD-intake
by pregnant rats was reported to affect both mother and fetal metabolism by enhancing lipogenesis
and hepatic endoplasmic reticulum stress [38]. The deleterious consequences of FRD administration
to pregnant mothers have been previously addressed. This diet is able to induce altered glucose
tolerance, hyperinsulinemia and reduced placental vascular area, thus leading to high risk for the
mother of developing gestational diabetes and preeclampsia [24]; moreover, their fetuses (embryonic
day 20) displayed increased BW. Interestingly, these dysfunctions were fully prevented by metformin
co-treatment [24], thereby indicating that impaired overall insulin sensitivity in the mother seems to
be mainly responsible for these FRD effects.
A relevant observation made throughout the present study is that the detrimental consequences on
AT endocrine function seen in F animals (which never consume FRD) are similar to those developed by
CF animals. In both situations, a higher basal leptinemia and hypertrophic adipocytes from RPAT were
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found. However, while FRD administration to the adult offspring is able to enhance adiponectinemia
in CF animals, we found that in F animals there was no change in plasma adiponectin concentration.
These findings highlight that the AT seems to be the main target for this diet-noxa, and highlight the
importance of the perinatal environment for an individual’s development.
It is well known that AT endocrine dysfunction associated to obesity is closely related to
adipocyte size, rather than to pad mass [39], and hypertrophic adipocytes are characterized by
impaired insulin sensitivity [40] and changes in the adipokine secretory pattern, including higher
leptin production [39,41]. Therefore, enhanced adipocyte size could well explain the hyperleptinemia
found in F animals despite AT mass decrease. Changes in LEP concentration could contribute to
impaired peripheral insulin sensitivity [42]. In the present study, the male offspring born to FRD-fed
gestating mothers displayed an apparent paradoxical situation; although, they have a lower AT mass
it has large adipocytes. These results could indicate a lower number of adipocytes. It has been found
that, in both humans and animal models, AT development occurs mainly during late pregnancy and
early postnatal life [43–45]. In fact, the ability to generate new adipocytes in adult life is limited; as a
consequence, the number of adipocytes remains relatively stable. Therefore, it is possible to speculate
that lower adipocyte numbers is a consequence of the alterations in APC determination during the
AT development, leading to a decrease in adipocyte generation [43]. Then, considering this unusual
situation, we next examined the cellular composition of the RPAT SVF to determine whether cell
hypertrophy and low pad mass could be a result of a lower APC number. Interestingly, a low number
of APCs, CD34+/CD45´/CD31´ [46] was found in F RPAT pads. This diminished APC number could
be responsible for an impaired adipogenic potential [45], and therefore leading to the development of
hypertrophic adipocytes. To our knowledge, this is the first study that shows changes in APC numbers
induced by excessive prenatal fructose intake.
Indeed, malnutrition during perinatal life could trigger changes in DNA methylation and
in histone acetylation/methylation, causing transcriptional changes of key factors involved in
adipogenesis (C/EBPα, PPARγ) [47,48]. Examples of this emerge from several studies, such
as those findings indicating that, during differentiation of 3T3-L1 cells, there is a modification
in the DNA methylation degree (i.e., PPAR, C/EBP, LEP, GULT4) [49–52] and in histone
methylation/acetylation [53], thus demonstrating the relevance of epigenetic regulation during
the adipogenic process. It is reasonable to speculate that, at least partially, AT dysfunction found
in offspring born from FRD mothers could be a consequence of epigenetic changes. Further
research is needed to better clarify the role of epigenetic modifications in our model. Given the
endocrine-metabolic alterations that we found in 60 day-old animals from FRD-fed mothers, we
proposed studying the response of these rats to a direct challenge with FRD in adult life. For this
purpose, we treated C and F 60 day-old rats with a FRD or a normal diet for three weeks (achieving
81 days of life), which has been widely used as an animal model of the human MS [30,54]. When
older (81-day-old) pups were studied, surprisingly, we found a remarkably deteriorated AT function
and metabolic state in FC pups. These rats had higher basal plasma levels of TG and GLU than CC
rats, despite no changes in insulinemia, whereas offspring’s hyperleptinemia and RPAT hypertrophic
adipocytes remained. In this regard, it has been previously reported that FRD intake in rats induced
severe basal hyperglycemia, with concomitant normoinsulinemia, accompanied by a high risk of
cardiovascular events [55]. In our experiments with 81 day-old rats, we noticed that the FRD challenge
to control animals (CF), increased circulating levels of TG, LEP and ADIPOQ, as well as RPAT pad
mass and adipocyte size, confirming our previous data [30]. Nevertheless, the consequences of direct
FRD administration to male offspring born to FRD-fed mothers (FF rats) were even more serious: they
showed increased caloric intake, body weight, and plasma levels of GLU, TG and LEP, thus indicating
they could be developing diabetes type 2.
Unlike the FC group and similar to findings in the 60-day-old F male offspring, there was no
increase in peripheral levels of ADIPOQ. It is well known that ADIPOQ acts as an insulin-sensitizing
factor [56]. In fact, ADIPOQ regulates glucose metabolism by improving insulin signaling pathway [57],
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enhancing liver and muscle glucose uptake, decreasing hepatic glucose output [58,59] and enhancing
fatty acid oxidation [60]. Therefore, an increase in ADIPOQ plasma levels observed in 81 day-old
control animals challenged with FRD (CF rats in Table 3) might play a protective role in carbohydrate
metabolism. These results are in full agreement with those previously reported from our laboratory [30].
The lack of a physiological increase in adiponectin secretion in FF animals is highly indicative of the
loss of its protective effect on carbohydrate dys-metabolism, contributing to the worsening of overall
metabolic derangements.
5. Conclusions
Overall, the present study shows that maternal consumption of fructose during gestation alters
offspring’s development causing metabolic and AT dysfunctions. At 60 days of age, rats born to
FRD-fed mothers showed impaired insulin sensitivity and profound AT dysfunction, evidenced by
hypertrophic adipocytes that secrete in vitro larger amounts of LEP, although with decreased AT mass.
This paradoxical situation could be the result, at least partially, of the reduced APC number, present
in RPAT from F rats. At 81 days old, the results of FC rats corroborate that the impact of FRD on
pups worsened the metabolic profile throughout their lifetime, even when they were not directly
exposed to this diet. These changes are clearly aggravated when the offspring directly consume FRD
during adulthood.
Considering that hypertrophic expansion of AT mass is a key marker for AT dysfunction, we
further conclude that high fructose consumption by pregnant mothers primes the first male generation
with a high risk of developing MS, obesity and type 2 diabetes. To our knowledge, this study is the first
to report changes in adipose precursor cells numbers, induced by in utero diet manipulation. However,
the impact of high fructose in utero on overall developmental programming of individuals requires
deeper research.
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